Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Ingresos
1,296
1,288
1,264
1,457
1,070
986
Crecimiento de los Ingresos (YoY)
3%
2%
-13%
36%
9%
1%
Costo de los ingresos
958
968
979
1,131
801
710
Utilidad bruta
338
319
284
326
269
275
Venta, General y Administración
181
182
175
171
154
140
Investigación y Desarrollo
44
46
45
47
42
37
Gastos de Operación
225
228
221
218
197
177
Otras Ingresos (Gastos) No Operativos
--
-2
-3
0
-1
-1
Ingreso antes de impuestos
84
62
45
116
86
87
Gasto por Impuesto a la Renta
18
16
2
26
8
14
Ingreso Neto
66
192
72
90
78
73
Crecimiento de la Utilidad Neta
-69%
167%
-20%
15%
7%
192%
Acciones en Circulación (Diluidas)
58.16
59.3
59.7
58.99
59.4
59.5
Cambio de Acciones (YoY)
-1%
-1%
1%
-1%
0%
0%
EPS (Diluido)
1.14
3.24
1.22
1.52
1.31
1.22
Crecimiento de EPS
-69%
166%
-20%
16%
7%
183%
Flujo de efectivo libre
100
99
16
-196
-126
20
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
26.08%
24.76%
22.46%
22.37%
25.14%
27.89%
Margen de operación
8.64%
6.98%
4.9%
7.41%
6.63%
9.93%
Margen de beneficio
5.09%
14.9%
5.69%
6.17%
7.28%
7.4%
Margen de flujo de caja libre
7.71%
7.68%
1.26%
-13.45%
-11.77%
2.02%
EBITDA
196
176
146
184
135
158
Margen de EBITDA
15.12%
13.66%
11.55%
12.62%
12.61%
16.02%
D&A para EBITDA
84
86
84
76
64
60
EBIT
112
90
62
108
71
98
Margen de EBIT
8.64%
6.98%
4.9%
7.41%
6.63%
9.93%
Tasa de Impuesto Efectiva
21.42%
25.8%
4.44%
22.41%
9.3%
16.09%
Estadísticas clave
Cierre Anterior
$21.5
Precio de apertura
$21.5
Rango del día
$21.5 - $21.5
Rango de 52 semanas
$19.17 - $23.17
Volumen
100
Volumen promedio
80
EPS (TTM)
1.29
Rendimiento de dividendos
--
Cap. de mercado
$1.2B
¿Qué es Corbion NV?
Corbion NV engages in the development, production, sale, and distribution of ingredients for food and biochemicals. The company is headquartered in Amsterdam, Noord-Holland and currently employs 2,403 full-time employees. The company operates through two segments: Biobased Ingredients and Biobased Innovations. The Biobased Ingredients segment comprises the Food business division and the Biochemicals business division. The Food business division develops preservation ingredients and microbial spoilage prevention products for the baking, meat, dairy, confectionery and beverage industries, and the Biochemicals business division produces bio-based chemicals derived from renewable resources such as sugar or starch. The Biobased Innovations segment creates new biotechnology business platforms, such aspoly lactic acid (PLA). The firm operates production sites in the United States, Brazil, Spain, the Netherlands and Thailand, and markets its products through a global network of retail offices.